Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CStone Pharmaceuticals and DotBio sign a global discovery collaboration and option agreement to expand emerging portfolio of next-generation innovative therapeutics 2021-11-09 08:05
BIORCHESTRA will present data on the therapeutic efficacy of their proprietary ASO against pathological miRNA, a key modulator of neuroinflammation and neurodegeneration, at the CTAD Meeting in Boston 2021-11-08 22:59
Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer 2021-11-08 21:47
BARDA and Clarivate Partner to Identify Therapeutics Which Can Be Repurposed as Medical Countermeasures to Chemical Exposure 2021-11-08 21:00
I-Mab and Roche Diagnostics Announce Strategic Collaboration to Co-Develop Companion Diagnostics Solutions for I-Mab's Innovative Pipeline at the 4th CIIE 2021-11-08 21:00
RedHill Biopharma and South Korea's Kukbo Co. Announce a Strategic Investment of Up To $10 Million in RedHill 2021-11-08 20:00
RadLink, Singapore's Leading Imaging Center, Adapts Lunit AI to Analyze Chest X-rays and Mammograms 2021-11-08 14:36
Ascletis and Suzhou Alphamab Expand their Partnership into Worldwide License Agreement for ASC22 (Envafolimab) to Treat Hepatitis B and Other Viral Diseases 2021-11-08 08:30
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:15
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:10
Innovent Publishes the Preclinical Results of IBI319 (Anti PD-1/CD137 Bispecific Antibody) in Nature Communications 2021-11-08 08:00
Bugworks Research Announces the First in Human Phase 1 Study of BWC0977 for the Treatment of Critical Bacterial Infections 2021-11-08 07:00
Wegovy™ Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity 2021-11-05 20:58
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline 2021-11-05 20:37
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-05 14:57
CIIE 2021: Offering new opportunities for COVID recovery 2021-11-05 11:30
ASH 2021 | Ascentage Pharma to Release Latest Data from Two Studies of Its Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a Chinese Study Demonstrating Complete Response 2021-11-05 09:05
ASH 2021 | Ascentage Pharma to Present Three Studies of Olverembatinib (HQP1351), a Novel Drug Candidate for the Treatment of Drug-Resistant Leukemia, in Abstracts Including One Oral Report at ASH Annual Meeting 2021-11-05 08:43
New Data at ASH 2021 Reinforces the Strength of Servier's Hematology Portfolio 2021-11-05 08:05
Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization 2021-11-05 05:00
1 324 325 326 327 328 894